跳至主要内容
临床试验/TCTR20181103002
TCTR20181103002已完成3 期

The Use of Stroke Mobile Application and Tele-medicine to shorten the time of Thrombolytic treatment at The Spoke Hospital of King Chulalongkorn Memorial Hospital

Chulalongkorn Stroke Center0 个研究点目标入组 64 人开始时间: 2018年11月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.Diagnosis of ischemic stroke causing measurable neurological deficit
  • 2.Onset of symptoms <4.5 hours before beginning treatment
  • 3.Aged ≥18 years

排除标准

  • 1.Significant head trauma or prior stroke in previous 3 months
  • 2.Symptoms suggest subarachnoid hemorrhage
  • 3.Arterial puncture at noncompressible site in previous 7 days
  • 4.History of previous intracranial hemorrhage,Intracranial neoplasm, arteriovenous malformation
  • 5.Elevated blood pressure (systolic >185 mm Hg or diastolic >110 mm Hg)
  • 6.Active internal bleeding
  • 7.Acute bleeding diathesis, including but not limited to
  • 8.Platelet count <100 000/mm³
  • 9.Heparin received within 48 hours, resulting in abnormally elevated aPTT greater than the upper limit of normal
  • 10.Current use of anticoagulant with INR >1.7 or PT >15 seconds
  • 11.Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory tests (such as aPTT, INR, platelet count, and ECT; TT; or appropriate factor Xa activity assays)
  • 12.Blood glucose concentration <50 mg/dL (2.7 mmol/L)
  • 13.CT demonstrates multilobar infarction (hypodensity >1/3 cerebral hemisphere)

研究者

发起方
Chulalongkorn Stroke Center

相似试验

The Use of Stroke Mobile Application and... | 临床试验